Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Katell Le Dû
Switches of Tyrosine-Kinase Inhibitors in Chronic Phase of Chronic Myeloid Leukemia in Real Life
American Journal of Hematology
Hematology
Transformed Waldenström Macroglobulinaemia: Clinical Presentation and Outcome. A Multi-Institutional Retrospective Study of 77 Cases From the French Innovative Leukemia Organization (FILO)
British Journal of Haematology
Hematology
Related publications
Complications of Tyrosine Kinase Inhibitors Therapy in Chronic Myeloid Leukemia - Chronic Phase
Revista de Chimie
Surfaces
Materials Science
Engineering
Materials Chemistry
Films
Coatings
Chemistry
Future Perspectives of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia
Chemotherapy: Open Access
Patient Preferences for Stopping Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Who 2016 Definition of Chronic Myeloid Leukemia and Tyrosine Kinase Inhibitors
Turkish Journal of Haematology
Hematology
Tyrosine Kinase Inhibitors as Initial Therapy for Patients With Chronic Myeloid Leukemia in Accelerated Phase
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Preventing and Managing Cardiovascular Toxicities of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
Cancer therapy & Oncology International Journal
Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Recommendations for Clinical Practice From the French Chronic Myeloid Leukemia Study Group
Cancer
Cancer Research
Oncology
Comparative Pharmacology of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia
International Journal of Clinical Pharmacology & Pharmacotherapy
Improving Outcomes in Chronic Myeloid Leukemia Over Time in the Era of Tyrosine Kinase Inhibitors
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology